Nano-X Imaging Ltd. (NNOX) company profile
Close on Nov 17, 2026Market cap $20.01MP/E –Yield –
About Nano-X Imaging
X-Ray Apparatus & Tubes & Related Irradiation Apparatus, SIC 3844
Nano-X Imaging Ltd. is an initial launch-stage medical imaging technology company that develops and commercializes digital X-ray source technology. Its primary products include the Nanox.ARC and Nanox.ARC X, which are multi-source 3D digital tomosynthesis systems, alongside the cloud-based Nanox.CLOUD platform. The company also provides teleradiology services and artificial intelligence image-analysis decision-support solutions. Nanox pursues three commercial business models: a subscription-based pay-per-scan medical screening service, direct equipment capital sales, and original equipment manufacturer licensing. Its target customers and users include physicians, diagnostic testing centers, medical imaging providers, hospitals, urgent care operators, and large healthcare systems.
The company operates internationally, having deployed dozens of systems for clinical, commercial, and demonstration purposes across multiple states in the United States as well as in other countries. It utilizes third-party manufacturing partners located in Israel and Singapore to support hardware production. Nano-X Imaging Ltd. is incorporated under the laws of the State of Israel, with its principal executive offices located in Petach Tikva, Israel.
Summary of the business section of Nano-X Imaging's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Nano-X Imaging Ltd.
- Founded
- 2018
- Headquarters
- Petach Tikva, L3
- Address
- Ofer Tech Park, 94 Shlomo Shmeltzer Road 4970602
- Phone
- 972-37359202
- Website
- nanox.vision
- Employees
- 197, Dec 31, 2025
- Industry
- X-Ray Apparatus & Tubes & Related Irradiation Apparatus
- Incorporated in
- L3
- Fiscal year ends
- December 31
- Auditor
- Kesselman & Kesselman, Tel Aviv
Stock & identifiers
- Ticker
- NNOX
- Exchange
- Nasdaq
- IPO date
- Aug 24, 2020
- Shares outstanding
- 70M, Dec 31, 2025
- Filer category
- Accelerated filer
- SEC CIK
- 1795251
- CUSIP
- M70700105
- FIGI
- BBG00RDSZ6J2
- Share class FIGI
- BBG00RDSZ6K0
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Erez Meltzer | Chief Executive Officer, Director | 151,027 |
| sharon saban | General Manager AI Division | 28,283 |
| Feler Marina Gofman | Chief Legal Officer | 28,283 |
| Attias Gali Yahav | Chief Corporate Resources | 28,283 |
| Guy Nathansohn | Chief Financial Officer | 50,000 |
| Cohen Tamar Aharon | EVP & Chief Marketing Officer | 28,283 |
| Ofir Koren | General Manager, ARC Division | 28,283 |
| James Dara | GM Source & Services Division | 28,283 |
| Ran Daniel | CFO | 5,950 |
| Dan S. Suesskind | Director | 110,000 |
| Noga Kainan | Director | 41,586 |
| Erez Alroy | Director | 17,075 |
| Nehama Ronen | Director | 7,792 |
| Michael Jackman | Director | 7,793 |
IPO
From the final prospectus (Form 424B4) and the first day of trading
Offering
- Type
- Initial public offering
- Final prospectus filed
- Aug 24, 2020
- Offer price
- $18.00
- Exchange
- Nasdaq
- First trading day
- Aug 21, 2020
- First-day close
- $21.70+20.6%
- Lock-up ends (est.)
- Feb 17, 2021
“The initial public offering price is $18.00 per ordinary share.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had 197 employees, of which 114 employees”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Aug 24, 2020 | IPO | Initial public offering priced (424B4 prospectus) |
| Aug 18, 2020 | Listing | Registration of securities on an exchange (Form 8-A) |
See a number that looks wrong?